Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Ophthalmology

 

2021: A boom year for health care M&A

The M&A market has roared out of Covid in the first quarter according to the HBI Panel Discussion. Are multiples likely to drop and what is investor appetite?

New off-payroll worker legislation could cost UK operators

Healthcare operators could fall foul of UK legislation designed to target tax avoidance which is due to come into force next month. For the first time, IR35 will force for-profit groups to assess the legal status of contractors receiving payments via an intermediary - and a failure to do so could prove costly.  HBI speaks to a specialist tax barrister to find out more.

Triton “invests” in Bergman – Aleris merger to follow?

PE firm Triton has agreed to "invest" in Dutch, Nordic and German ambulatory clinic operator Bergman Clinics, possibly implying it is not buying control from NPM Capital and the Malensteins who are retaining stakes. Triton would not comment on the size of the stake nor on our speculation it plans to merge Bergman with Nordic operator Aleris.

Bergman buys German cosmetic group

Netherlands-based ambulatory and ophthalmology clinic group Bergman Clinics, currently exploring a sale that could raise over €1bn, has acquired German aesthetic surgical treatments platform Medical One.

Big Picture: Europe’s Ophthalmology Market

Topics include: Bouncing back from the financial hit of COVID as business becomes brisker Meeting pent-up demand, and the need to relieve pressure on public waiting lists How to persuade payors of the benefits of technology – the advantage of digital pathways Post-COVID consolidation pushes and opportunities; is bigger always beautiful? Panel includes: Tobias Koesters, Partner, […]

Appointment of new Artemis CEO lends weight to sale rumours

The CEO of Artemis Group, Germany's second largest ophthalmology chain by revenue, is stepping down from his position as CEO next week to be replaced by the former MD of German rehabilitation specialist Median Kliniken, who is also an ex McKinsey & Company consultant and investment house managing director. A source tells us this is being done in anticipation of a sale.

Find Us